May 13 (Reuters)-
Takara Bio Inc.
CONSOLIDATED FINANCIAL HIGHLIGHTS
(in billions of yen unless specified)
Year ended Year ended Year to NEXT
Mar 31, 2025 Mar 31, 2024 Mar 31, 2026 YEAR
LATEST YEAR-AGO COMPANY COMPANY
RESULTS RESULTS FORECAST H1 FORECAST
Sales 45.04 43.51 52.50 21.30
(+3.5 pct) (-44.3 pct) (+16.6 pct) (+7.8 pct)
Operating 2.26 3.00 2.50 loss 1.45
(-24.6 pct) (-85.4 pct) (+10.5 pct)
Recurring 2.59 3.41 2.50 loss 1.43
(-23.9 pct) (-83.5 pct) (-3.6 pct)
Net
Net 1.04 1.48 1.30 loss 1.32
(-29.6 pct) (-90.8 pct) (+24.8 pct)
EPS 8.65 yen 12.30 yen 10.08 yen loss 10.96 yen
Ann Div 17.00 yen 17.00 yen 17.00 yen
-Q2 Div NIL NIL NIL
-Q4 Div 17.00 yen 17.00 yen 17.00 yen
NOTE - Takara Bio Inc..
*Second Net profit row denotes profit attributable to owners ofthe parent
To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4974.T